skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Screening with GenoType® MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes
Screening with GenoType® MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Screening with GenoType® MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes

Mendoza-Ticona, A. ; Mitnick, C. D. ; Obregón, G. ; Alarcón, V.

The international journal of tuberculosis and lung disease, 2023-12, Vol.27 (12), p.949-951 [Periódico revisado por pares]

Paris: International Union Against Tuberculosis and Lung Disease

Sem texto completo

Citações Citado por
2
GBC: a parallel toolkit based on highly addressable byte-encoding blocks for extremely large-scale genotypes of species
GBC: a parallel toolkit based on highly addressable byte-encoding blocks for extremely large-scale genotypes of species
Material Type:
Artigo 		Adicionar ao Meu Espaço

GBC: a parallel toolkit based on highly addressable byte-encoding blocks for extremely large-scale genotypes of species

Zhang, Liubin ; Yuan, Yangyang ; Peng, Wenjie ; Tang, Bin ; Li, Mulin Jun ; Gui, Hongsheng ; Wang, Qiang ; Li, Miaoxin

Genome Biology, 2023-04, Vol.24 (1), p.76-76, Article 76 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Net House Evaluation of Rice Land Races against Brown Plant Hopper and White Backed Plant Hopper
Net House Evaluation of Rice Land Races against Brown Plant Hopper and White Backed Plant Hopper
Material Type:
Artigo 		Adicionar ao Meu Espaço

Net House Evaluation of Rice Land Races against Brown Plant Hopper and White Backed Plant Hopper

Rath, P C ; Meher, J ; Bose, L K ; Dash, S K ; Parmeswaran, C ; Pandi, G G P ; Gowda, G Basana ; Adak, Totan ; Patil, N K B ; Annamalai, M ; Bag, M K ; Prabhukarthikeyan, S R ; Raghu, S ; Baite, M S ; Prasanthi, G ; Subudhi, H N

Environment and ecology, 2022-04, Vol.40 (2C), p.913 [Periódico revisado por pares]

Kalyani: MKK Publications

Texto completo disponível

Citações Citado por
4
Statistical approach to detecting maternal genetic effects
Statistical approach to detecting maternal genetic effects
Material Type:
Artigo 		Adicionar ao Meu Espaço

Statistical approach to detecting maternal genetic effects

Casci, Tanita

Nature reviews. Genetics, 2012-04, Vol.13 (4), p.223-223 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

Citações Citado por
5
O‐037: Genotype 5 HCV – patient characteristics, resistance mutations and treatment outcomes
O‐037: Genotype 5 HCV – patient characteristics, resistance mutations and treatment outcomes
Material Type:
Artigo 		Adicionar ao Meu Espaço

O‐037: Genotype 5 HCV – patient characteristics, resistance mutations and treatment outcomes

Journal of viral hepatitis, 2018-06, Vol.25 (S2), p.24-24 [Periódico revisado por pares]

Oxford: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
P1‐080: Prevalence of baseline NS5A resistance associated sequences (RAS) in treatment naïve patients with genotype 1 and 3 in Canada
P1‐080: Prevalence of baseline NS5A resistance associated sequences (RAS) in treatment naïve patients with genotype 1 and 3 in Canada
Material Type:
Artigo 		Adicionar ao Meu Espaço

P1‐080: Prevalence of baseline NS5A resistance associated sequences (RAS) in treatment naïve patients with genotype 1 and 3 in Canada

Journal of viral hepatitis, 2018-06, Vol.25 (S2), p.63-64 [Periódico revisado por pares]

Oxford: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
7
LBP‐006: Sofosbuvir‐ Daclatasvir: Effectiveness among cirrhotic and non‐cirrhotic genotype 1 to 4 HCV patients, in real world settings
LBP‐006: Sofosbuvir‐ Daclatasvir: Effectiveness among cirrhotic and non‐cirrhotic genotype 1 to 4 HCV patients, in real world settings
Material Type:
Artigo 		Adicionar ao Meu Espaço

LBP‐006: Sofosbuvir‐ Daclatasvir: Effectiveness among cirrhotic and non‐cirrhotic genotype 1 to 4 HCV patients, in real world settings

Journal of viral hepatitis, 2018-06, Vol.25 (S2), p.197-197 [Periódico revisado por pares]

Oxford: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
P1‐102: Effectiveness and utilization of elbasvir/grazoprevir in HCV genotype 1 and 4 infection in the veteran affairs healthcare system in the United States
P1‐102: Effectiveness and utilization of elbasvir/grazoprevir in HCV genotype 1 and 4 infection in the veteran affairs healthcare system in the United States
Material Type:
Artigo 		Adicionar ao Meu Espaço

P1‐102: Effectiveness and utilization of elbasvir/grazoprevir in HCV genotype 1 and 4 infection in the veteran affairs healthcare system in the United States

Journal of viral hepatitis, 2018-06, Vol.25 (S2), p.75-76 [Periódico revisado por pares]

Oxford: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
9
P2‐089: Heterogenous distribution of HCV genotypes and outcome of treatment
P2‐089: Heterogenous distribution of HCV genotypes and outcome of treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

P2‐089: Heterogenous distribution of HCV genotypes and outcome of treatment

Journal of viral hepatitis, 2018-06, Vol.25 (S2), p.151-152 [Periódico revisado por pares]

Oxford: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
P2‐038: Prevalence of baseline NS5A inhibitor resistance‐associated variants in Brazilian patients infected with genotypes 1 and 3
P2‐038: Prevalence of baseline NS5A inhibitor resistance‐associated variants in Brazilian patients infected with genotypes 1 and 3
Material Type:
Artigo 		Adicionar ao Meu Espaço

P2‐038: Prevalence of baseline NS5A inhibitor resistance‐associated variants in Brazilian patients infected with genotypes 1 and 3

Journal of viral hepatitis, 2018-06, Vol.25 (S2), p.127-128 [Periódico revisado por pares]

Oxford: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (366.933)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (385.152)
  2. Anais de Congresso  (1.203)
  3. Book Chapters  (177)
  4. magazinearticle  (97)
  5. Resenhas  (55)
  6. Web Resources  (11)
  7. Dissertações  (1)
  8. Conjunto de Dados  (1)
  9. Mais opções open sub menu

Assunto 

  1. Science & Technology  (329.897)
  2. Life Sciences & Biomedicine  (303.257)
  3. Genotype  (237.427)
  4. Humans  (192.962)
  5. Female  (123.775)
  6. Male  (116.144)
  7. Genotype & Phenotype  (100.110)
  8. Genotypes  (87.734)
  9. Biological And Medical Sciences  (79.999)
  10. Animals  (73.717)
  11. Adult  (67.649)
  12. Middle Aged  (64.350)
  13. Phenotype  (54.929)
  14. Mutation  (50.387)
  15. Genetics & Heredity  (49.404)
  16. Alleles  (45.999)
  17. Medical Sciences  (45.336)
  18. Genes  (43.859)
  19. Fundamental And Applied Biological Sciences. Psychology  (43.726)
  20. Aged  (41.712)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1961  (855)
  2. 1961Até1976  (4.772)
  3. 1977Até1992  (14.997)
  4. 1993Até2009  (116.547)
  5. Após 2009  (249.485)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (379.423)
  2. Japonês  (52.293)
  3. Português  (3.249)
  4. Russo  (1.907)
  5. Espanhol  (1.562)
  6. Alemão  (1.356)
  7. Francês  (1.210)
  8. Chinês  (1.039)
  9. Tcheco  (379)
  10. Eslovaco  (305)
  11. Polonês  (295)
  12. Turco  (279)
  13. Norueguês  (251)
  14. Coreano  (209)
  15. Italiano  (141)
  16. Húngaro  (112)
  17. Serbian  (100)
  18. Persa  (89)
  19. Ucraniano  (82)
  20. Romeno  (52)
  21. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.